STATE OF HEALTH CARE SUMMIT //

AGENDA
February 13, 2015
8:30 AM - 9:15 AM
Keynote Address: What Lies Ahead for Biotech in 2015?
The day will kick off with a keynote addressing trends that are shaping the biotech
industry in 2015.
Speaker:
Jeffrey R. Greene, Global Transactions Leader, Life Sciences, Ernst & Young
9:15 AM 9:30 AM
Address: Health-Care Through a Washington Lens
A discussion of key items on Washington's health-care legislative agenda for 2015
including bipartisan efforts to enact a permanent "doc fix" solution, attempts by
Republicans to roll back some provisions of the Affordable Care Act and growing
congressional interest in reforming the FDA.
Speaker:
Brian Rye, Government Analyst, Healthcare Policy, Bloomberg Intelligence

9:30 AM - 10:00 AM
Panel: Medical Device Innovation Drives Growth Higher
This panel will investigate new therapies such as transcatheter heart valves and
drug-coated balloons.
Speakers:
Dr. Samuel Jacob Scheinerman, Chair of Cardiovascular & Thoracic Surgery,
Lenox Hill Hospital (Member of North Shore-LIJ Health System)
Dr. Mathew R. Williams, Chief of Adult Cardiac Surgery and Director of
Interventional Cardiology at NYU Langone Medical Center
Jason McGorman, Analyst, Bloomberg Intelligence

10:00 AM - 10:30 AM
Panel: Innovation in Liver Diseases: HCV and NASH
The panel will discuss advances in the treatment of hepatitis C and fatty liver
disease.
Speakers:
Keith Hoffman, V.P. Scientific Affairs, AdverseEvents
Dr. Hillel Tobias, NYU
Dr. M. Isabel Fiel, Mt. Sinai
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence

10:40 AM - 11:10 AM
Panel: Investor Outlook 2015
A discussion of what investors are most interested in for 2015.
Speakers:
Les Funtleyder, Healthcare Portfolio Manager, E Squared Asset Management
Barbara Ryan, Partner, Clermont Partners
Leon Chen, Ph.D., Venture Partner, OrbiMed
Andrew Hilgenbrink, Director at Highland Capital Healthcare Partners
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence

11:10 AM - 11:40 AM
Panel: Cancer Innovation
The panel of key opinion leaders will discuss advances with immunotherapy and
novel approaches like CAR-T in blood cancers.
Speakers:
Michel Sadelain, MD, PhD, Memorial Sloan Kettering, Co-founder, Juno
Therapeutics
Peter Emtage, Ph.D., Vice President, Synthetic Immunology, Intrexon
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence

11:40-11:55 Break

11:55 AM 12:55 PM
Address: Bloomberg-BIO Joint Survey on 2015
Results of our survey of industry stakeholders and investors will be revealed.
Speakers:
Mark Schoenebaum, Senior Managing Director, Head of Evercore ISI's Health Care
Research Team
Bernard Fallon, Senior Manager, Industry Research & Event Programming, BD,
BIO
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence

12:55-1:10 Break
1:10 PM - 1:45 PM
Panel: What's the Cost of Pricing Pressure?
Drug developers have been facing pushback on the price of drugs. The panel will
explore ways in which the healthcare system will deal with the rising price of novel
therapies.
Speakers:
Robert Zirkelbach, Senior Vice President, PhRMA
Dr. Robert Dubois, Chief Science Officer, National Pharmaceutical Council
Michael Kuehn, Partner, Simon Kucher Partners
Tanisha Carino, EVP, Life Sciences Avalere
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence

1:45 PM - 2:15 PM
Panel: The Legal and Regulatory Obstacles for Biosimilars
Experts will clarify complexities in the regulatory pathway for biosimilars and
ramifications of ongoing litigation.
Speakers:
Rodeina Challand, Executive Director Biosimilar Development at PRA International
Kevin M. Nelson, Partner, Duane Morris
Alex Waldron, VP of Global Commercial Operations, Epirus Biopharmaceuticals
Aude Gerspacher, Senior Analyst, Bloomberg Intelligence
Liz Krutoholow, Analyst, Bloomberg Intelligence

2:15 PM - 2:45 PM
Panel: Will ACA Reign Supreme in 2015?
A discussion of on-going challenges to the ACA and implications for the industry.
Speakers:
Michael Kolber, Attorney, Manatt, Phelps & Phillips, LLP
Greg Nersessian, Principal at Health Management Associates
Jason McGorman, Analyst, Bloomberg Intelligence
Aude Gerspacher, Senior Analyst, Bloomberg Intelligence

2:45 PM - 3:15 PM
Panel: The Commercial Evolution of the U.S. Biosimilars Market
The panel will discuss commercialization strategies and nuances to consider in
developing and launching different classes of biosimilar drugs in the U.S..
Speakers:
Patrick Liu, Global Head of Bioanalytical Sciences and Technologies,Teva
Pharmaceuticals
Robert Schickel, Senior Engagement Manager, Campbell Alliance
John Carlsen, Vice President, Covance
Sam Fazeli, Head of Research, EMEA, Bloomberg Intelligence
Asthika Goonewardene, Senior Analyst, Bloomberg Intelligence